Heart failure Trials in Bradenton, United States
Conditions / Heart failure / Bradenton, United States
Clinical trials for Heart failure investigate a range of treatment strategies and patient populations.
19 total trials for this combination
Showing top 10 of 19 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06008197 | A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients | RECRUITING | — |
| NCT03723265 | Personalized CRT - PSR | COMPLETED | — |
| NCT01660035 | The Product Surveillance Registry REVERSE Post Approval Study | COMPLETED | — |
| NCT01361672 | Model 4296 Left Ventricular (LV) Lead Chronic Performance Study | COMPLETED | — |
| NCT04435626 | Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40% | COMPLETED | PHASE3 |
| NCT03315143 | Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk | TERMINATED | PHASE3 |
| NCT00271180 | Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products | RECRUITING | — |
| NCT03037931 | Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study | COMPLETED | PHASE3 |
| NCT03035474 | Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure | COMPLETED | NA |
| NCT02111564 | A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients | COMPLETED | PHASE3 |